Enacademic 🎓Analogindex
49 subscribers
77.3K photos
5 videos
249K links
Download Telegram
*Stocks edge higher, Tesla, Powell in focus, Pfizer slumps, Taylor Swift shines, Lululemon enters S&P 500 - 5 Things To Know*

Five things you need to know before the market opens on Monday October 16:1. -- Stock Market Today: Stocks steady, oil slips as markets eye middle east tensions Investors are looking ahead cautiously to a busy week on Wall Street as tension in the middle east escalate and inflation concerns continue to clip sentiment.2. -- Tesla earnings, Jerome Powell speech, retail sales highlight key week on Wall Street Wall Street bulls face a crucial test this week as the third quarter earnings season shifts into full gear amid rising geopolitical tensions and renewed inflation risks.3. -- Pfizer slumps after slashing full-year profit forecast on tumbling Covid sales Pfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year.4. -- Lululemon stock leaps as shares are tapped to replace Activision in the S&P 500 Lululemon, which is now worth around $50 billion, will replace Activision Blizzard in the S&P 500 following the latter's takeover by Microsoft.5. -- Taylor Swift 'Eras Tour' Film smashes box office records but can't lift AMC Mega star Taylor Swift's Eras Tour movie likely drew $120 million in box office receipts this weekend, the most-ever for a concert film and a record for any October movie release.
[Read more...](https://www.thestreet.com/investing/stocks/stocks-higher-tesla-powell-in-focus-pfizer-taylor-swift-lululemon)
Stocks edge higher, Tesla, Powell in focus, Pfizer slumps, Taylor Swift shines, Lululemon enters S&P 500 - 5 Things To Know

Five things you need to know before the market opens on Monday October 16:1. -- Stock Market Today: Stocks steady, oil slips as markets eye middle east tensions Investors are looking ahead cautiously to a busy week on Wall Street as tension in the middle east escalate and inflation concerns continue to clip sentiment.2. -- Tesla earnings, Jerome Powell speech, retail sales highlight key week on Wall Street Wall Street bulls face a crucial test this week as the third quarter earnings season shifts into full gear amid rising geopolitical tensions and renewed inflation risks.3. -- Pfizer slumps after slashing full-year profit forecast on tumbling Covid sales Pfizer said slumping demand for its Comirnaty covid vaccine and its Paxlovid antiviral treatment will mean sharply lower revenues for the full year.4. -- Lululemon stock leaps as shares are tapped to replace Activision in the S&P 500 Lululemon, which is now worth around $50 billion, will replace Activision Blizzard in the S&P 500 following the latter's takeover by Microsoft.5. -- Taylor Swift 'Eras Tour' Film smashes box office records but can't lift AMC Mega star Taylor Swift's Eras Tour movie likely drew $120 million in box office receipts this weekend, the most-ever for a concert film and a record for any October movie release.
Read more...
*Смартфоны с iOS 17 начали самопроизвольно выключаться ночью*

Если вам особенно не повезёт, останетесь без важного звонка или даже будильника.
[Read more...](https://lifehacker.ru/iphone-vyklyuchayutsya-nochyu/)
*Lululemon stock leaps as shares are tapped to replace Activision in the S&P 500*

Lululemon Athletic (LULU) - Get Free Report shares powered higher in pre-market trading following confirmation that the athletic apparel group will replace Activision Blizzard (ATVI) - Get Free Report in the S&P 500. Lululemon, with a market value of around $48 billion, will enter the benchmark on Wednesday, S&P Dow Jones Indices said in a weekend statement, replacing Activision following its $69 billion takeover by Microsoft (MSFT) - Get Free Report, which was completed last week. Stocks that are added to the S&P 500, as well as other benchmarks, often see a solid near-term boost as investors add their shares to funds that track the major indices. Shares in the group have risen nearly 200% over the past five years, adding billions to its market value, as its continues to win over shoppers in the key demographic of upscale athletic apparel and fitness in the U.S. while expanding its operations to overseas markets. Earlier this summer, Lululemon lifted its forecast full-year revenues to between $9.51 billion and $9.57 billion following better-than-expected second quarter earnings that contrasted muted outlooks from sports apparel rivals such as Nike (NKE) - Get Free Report and Adidas. The group also unveiled plans for a five year content and apparel partnership with Peloton Interactive PTON late last month that will see it become the primary athletic apparel partner on the connected fitness group's website and in its retail stores. Lululemon also said it would stop selling its 'Mirror' fitness hardware, which it purchased for $500 million in 2020, by the end of the year, but would continue servicing existing customers with content from Peloton. . Lululemon shares were marked 5.1% higher in pre-market trading to indicate an opening bell price of $396.97 each, a move that would nudge the stock into positive territory over the past six months. Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
[Read more...](https://www.thestreet.com/investing/lululemon-stock-leaps-as-shares-tapped-to-replace-activision-in-s-p-500)
Lululemon stock leaps as shares are tapped to replace Activision in the S&P 500

Lululemon Athletic (LULU) - Get Free Report shares powered higher in pre-market trading following confirmation that the athletic apparel group will replace Activision Blizzard (ATVI) - Get Free Report in the S&P 500. Lululemon, with a market value of around $48 billion, will enter the benchmark on Wednesday, S&P Dow Jones Indices said in a weekend statement, replacing Activision following its $69 billion takeover by Microsoft (MSFT) - Get Free Report, which was completed last week. Stocks that are added to the S&P 500, as well as other benchmarks, often see a solid near-term boost as investors add their shares to funds that track the major indices. Shares in the group have risen nearly 200% over the past five years, adding billions to its market value, as its continues to win over shoppers in the key demographic of upscale athletic apparel and fitness in the U.S. while expanding its operations to overseas markets. Earlier this summer, Lululemon lifted its forecast full-year revenues to between $9.51 billion and $9.57 billion following better-than-expected second quarter earnings that contrasted muted outlooks from sports apparel rivals such as Nike (NKE) - Get Free Report and Adidas. The group also unveiled plans for a five year content and apparel partnership with Peloton Interactive PTON late last month that will see it become the primary athletic apparel partner on the connected fitness group's website and in its retail stores. Lululemon also said it would stop selling its 'Mirror' fitness hardware, which it purchased for $500 million in 2020, by the end of the year, but would continue servicing existing customers with content from Peloton. . Lululemon shares were marked 5.1% higher in pre-market trading to indicate an opening bell price of $396.97 each, a move that would nudge the stock into positive territory over the past six months. Action Alerts PLUS offers expert portfolio guidance to help you make informed investing decisions. Sign up now.
Read more...
*Эффект Бэтмена: как сохранять самообладание в любой ситуации*

Сознательное раздвоение личности иногда идёт только на пользу.
[Read more...](https://lifehacker.ru/effekt-betmena/)
*Rite Aid seeks Chapter 11 bankruptcy protection amid Opioid lawsuits, slumping sales*

Rite Aid Corporation (RAD) - Get Free Report shares found support in pre-market trading Monday after the retail pharmacy chain filed for Chapter 11 bankruptcy protection late Sunday, citing slumping sales and litigation costs linked to the nation's opioid crisis. The group said it hoped to continue operations as it seeks time from the court process to restructure its debts and strengthen its balance sheet, adding it secured around $3.45 billion in so-called 'debtor-in-possession' funding from a group of lenders that will sit atop its existing debts, as well as its shareholders, in the event of a complete company liquidation. Rite Aid also appointed turnaround expert Jeffrey Stein to run the group during its Chapter 11 process, which allows companies time to engage creditors under the supervision of a court-appointed judge, to either stabilize its business and re-emerge as a separate entity or seek liquidation. Stein replaces Elizabeth Burr, who was acting as interim CEO following the departure of Heyward Donigan in June. "Jeff is a proven leader with a strong track record of guiding companies through financial restructurings," said Chairman Bruce Bodaken. "We look forward to benefitting from his contributions and leveraging his expertise as we strengthen Rite Aid’s foundation and position the business for long-term success.” Rite Aid listed assets and liabilities of between $1 billion and $10 billion in its Chapter 11 filing with the U.S. Bankruptcy Court in New Jersey, noting it had around 100,000 overall creditors. Its overall debt was pegged at $8.6 billion as of June 3, the filing indicated, with repayment dates as early as 2025. Slumping sales, particularly linked to Covid vaccines and treatments, added to Rite Aid's woes following a March compliant from the U.S. Department of Justice that it ignored "red flags' in filing hundreds of thousands of Illegal prescriptions over a five year period ending in June of 2019. "Rite Aid’s pharmacists repeatedly filled prescriptions for controlled substances with obvious red flags, and Rite Aid intentionally deleted internal notes about suspicious prescribers," the DoJ said. "These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid’s stores.” Rite Aid said it would likely close more of its 2,300 stores over seventeen states, while steepening cost-cutting efforts, as part of its turnaround plans, and is looking to sell its Elixir Solutions pharmacy benefits division to Frederick Howe-owned MedImpact, subject to court approval. Retail pharmacy group has been hit hard by both slumping Covid vaccine sales, which keep potential shoppers from visiting stores, as well as a pullback in consumer discretionary spending linked to elevated inflation. Earlier this month, Walgreens Boots Alliance (WBA) - Get Free Report posted weaker-than-expected fiscal-fourth-quarter earnings and issued a muted outlook for near-term profits, while Pfizer (PFE) - Get Free Report slashed its full-year profit forecast late Friday citing weakening demand for its Covid vaccines and treatments. Rite Aid shares were marked 4.9% higher from Friday's closing levels in pre-market trading to indicate an opening bell price of $68 cents per share. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/rite-aid-seeks-chapter-11-bankruptcy-amid-opioid-lawsuits-sliding-sales)
Rite Aid seeks Chapter 11 bankruptcy protection amid Opioid lawsuits, slumping sales

Rite Aid Corporation (RAD) - Get Free Report shares found support in pre-market trading Monday after the retail pharmacy chain filed for Chapter 11 bankruptcy protection late Sunday, citing slumping sales and litigation costs linked to the nation's opioid crisis. The group said it hoped to continue operations as it seeks time from the court process to restructure its debts and strengthen its balance sheet, adding it secured around $3.45 billion in so-called 'debtor-in-possession' funding from a group of lenders that will sit atop its existing debts, as well as its shareholders, in the event of a complete company liquidation. Rite Aid also appointed turnaround expert Jeffrey Stein to run the group during its Chapter 11 process, which allows companies time to engage creditors under the supervision of a court-appointed judge, to either stabilize its business and re-emerge as a separate entity or seek liquidation. Stein replaces Elizabeth Burr, who was acting as interim CEO following the departure of Heyward Donigan in June. "Jeff is a proven leader with a strong track record of guiding companies through financial restructurings," said Chairman Bruce Bodaken. "We look forward to benefitting from his contributions and leveraging his expertise as we strengthen Rite Aid’s foundation and position the business for long-term success.” Rite Aid listed assets and liabilities of between $1 billion and $10 billion in its Chapter 11 filing with the U.S. Bankruptcy Court in New Jersey, noting it had around 100,000 overall creditors. Its overall debt was pegged at $8.6 billion as of June 3, the filing indicated, with repayment dates as early as 2025. Slumping sales, particularly linked to Covid vaccines and treatments, added to Rite Aid's woes following a March compliant from the U.S. Department of Justice that it ignored "red flags' in filing hundreds of thousands of Illegal prescriptions over a five year period ending in June of 2019. "Rite Aid’s pharmacists repeatedly filled prescriptions for controlled substances with obvious red flags, and Rite Aid intentionally deleted internal notes about suspicious prescribers," the DoJ said. "These practices opened the floodgates for millions of opioid pills and other controlled substances to flow illegally out of Rite Aid’s stores.” Rite Aid said it would likely close more of its 2,300 stores over seventeen states, while steepening cost-cutting efforts, as part of its turnaround plans, and is looking to sell its Elixir Solutions pharmacy benefits division to Frederick Howe-owned MedImpact, subject to court approval. Retail pharmacy group has been hit hard by both slumping Covid vaccine sales, which keep potential shoppers from visiting stores, as well as a pullback in consumer discretionary spending linked to elevated inflation. Earlier this month, Walgreens Boots Alliance (WBA) - Get Free Report posted weaker-than-expected fiscal-fourth-quarter earnings and issued a muted outlook for near-term profits, while Pfizer (PFE) - Get Free Report slashed its full-year profit forecast late Friday citing weakening demand for its Covid vaccines and treatments. Rite Aid shares were marked 4.9% higher from Friday's closing levels in pre-market trading to indicate an opening bell price of $68 cents per share. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...
*Как приготовить тыквенный латте как в «Старбаксе»*

Согревающий напиток со вкусом тыквенного пирога.
[Read more...](https://burninghut.ru/tykvennoe-latte/?utm_source=lifehacker.ru&utm_medium=referral&utm_campaign=teaser&utm_content=tykvennoe-latte)
*Xiaomi представила умный наматрасник с подогревом и режимом уничтожения клещей*

Вся электроника вынесена во внешний блок, поэтому бельё абсолютно безопасно (уверяет производитель).
[Read more...](https://lifehacker.ru/mijia-plumbing-blanket-anons/)
*Как заморозить опята на зиму: 3 лучших способа*

Грибы можно заготовить свежими, варёными или в виде фарша.
[Read more...](https://lifehacker.ru/kak-zamorozit-opyata/)
*7 основ безопасности в интернете, которыми мы часто пренебрегаем*

Эти простые действия защитят от неприятностей.
[Read more...](https://lifehacker.ru/bezopasnost-v-internete/)
*We Asked 3 Pro Cleaners to Name the Best Sponge*

There was a clear winner. READ MORE...
[Read more...](https://www.apartmenttherapy.com/best-sponge-pro-cleaners-37325422?utm_source=RSS&utm_medium=feed&utm_campaign=Category%2FChannel%3A+main)
*Stock Market Today: Stocks gain, oil edges higher as markets eye middle east tensions*

Updated at 8:45 am EDT U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in early New York dealing To 4.685% as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.22% lower at 106.411 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.060%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents higher at $91.30per barrel in early New York dealing while WTI crude contracts for November, which are linked to U.S. gasoline prices, added 51 cents to $88.20 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a 19 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 155 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 38 points higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.25% higher in mid-day Frankfurt trading while Britain's FTSE 100 edged 0.31% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
[Read more...](https://www.thestreet.com/investing/stock-market-today-stocks-steady-as-markets-eye-middle-east-tensions)
Stock Market Today: Stocks gain, oil edges higher as markets eye middle east tensions

Updated at 8:45 am EDT U.S. equity futures nudged higher Monday, while the dollar slipped lower against its global peers and Treasury yields steadied, as investors braced for a crucial week on Wall Street while closely tracking the escalating conflict in the middle east. Global investors aren't yet in 'risk-off' mode as a result of the war in Israel, which is massing troops on the border of Gaza and preparing for a ground invasion following last week's attacks from Hamas, but they are moving cautiously. Benchmark 10-year Treasury note yields, however, edged higher in early New York dealing To 4.685% as the prospect of higher Fed rates, as well as renewed inflation risks, trumped safe-haven flows. The U.S. dollar index, another traditional 'flight-to-safety' trade, was marked 0.22% lower at 106.411 against a basket of its global peers while 2-year note yields were up 2 basis points at 5.060%. Oil prices, as well, have yet to react to the weekend events, which have included warnings from Iran, a key weapons supplier to Hamas, that it could become involved in the conflict should Israel mount its ground assault on Gaza over the coming days. Brent crude futures for December delivery, the global pricing benchmark, were last seen trading 41 cents higher at $91.30per barrel in early New York dealing while WTI crude contracts for November, which are linked to U.S. gasoline prices, added 51 cents to $88.20 per barrel. With the conflict isolated, at least for the moment, investors are likely to focus instead on the prospects for another Fed rate hike following the emergence of renewed inflation risks last week and minutes from the central bank's September policy meeting that suggest the need for at least one more increase between now and the end of the year. To that end, Thursday's slate of Fed speakers, including an address to the Economic Club of New York by Chairman Jerome Powell, will be keenly watched for clues as to the Fed's near-term rate path. A busy earnings week also lies ahead, with 56 56 S&P 500 companies set to report September quarter earning over the next five days, following on from a solid start last week paced by better-than-expected updates from UnitedHealth Group (UNH) - Get Free Report and JPMorgan Chase (JPM) - Get Free Report. Data from the London Stock Exchange Group suggests collective S&P 500 profits are likely to rise 2.2% from last year to a share-weighted $468.8 billion, paced by the communications services sector (which includes Google parent Alphabet (GOOGL) - Get Free Report and Facebook owner Meta Platforms (META) - Get Free Report). Heading into the start of the trading day on Wall Street, futures contracts tied to the S&P 500, which is up 0.93% for the month, are indicating a 19 point opening bell gain while those linked to the Dow Jones Industrial Average are priced for a firmer 155 point advance thanks in part to pre-market gains for oil majors Chevron (CVX) - Get Free Report and Exxon (XOM) - Get Free Report. The Nasdaq is called just 38 points higher, with the tech-focused index held down by slumping chip stocks following a report that the U.S. is ready to tighten restrictions on the sale of advanced semiconductors and technologies to China. In overseas markets, Europe's Stoxx 600 was marked 0.25% higher in mid-day Frankfurt trading while Britain's FTSE 100 edged 0.31% higher in London. In Asia, Japan's Nikkei 225 slumped just over 2% as markets played catch-up to the Friday sell-off on Wall Street, while the region-side MSCI ex-Japan benchmark fell 0.68% into the close of trading. Get investment guidance from trusted portfolio managers without the management fees. Sign up for Action Alerts PLUS now.
Read more...